Indivior PLC (LON:INDV – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1,238 and traded as low as GBX 1,230. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares trading hands.
Indivior Trading Up 1.6%
The stock has a market cap of £1.93 billion, a PE ratio of -1,026.48, a PEG ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of -141.86, a quick ratio of 1.52 and a current ratio of 0.90. The stock has a fifty day moving average price of GBX 1,238 and a 200 day moving average price of GBX 1,238.
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.
Read More
- Five stocks we like better than Indivior
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
